D.E. Shaw & Co’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
33,796
-242,043
| -88% | -$8.72M | ﹤0.01% | 2136 |
|
|
2025
Q1 | $8.59M | Sell |
275,839
-885,465
| -76% | -$27.6M | 0.01% | 1081 |
|
|
2024
Q4 | $29.6M | Buy |
1,161,304
+228,964
| +25% | +$5.84M | 0.02% | 531 |
|
|
2024
Q3 | $26.4M | Buy |
932,340
+898,728
| +2,674% | +$25.4M | 0.02% | 560 |
|
|
2024
Q2 | $886K | Buy |
+33,612
| New | +$886K | ﹤0.01% | 2224 |
|
|
2024
Q1 | – | Sell |
-13,387
| Closed | -$376K | – | 3362 |
|
|
2023
Q4 | $376K | Sell |
13,387
-384,459
| -97% | -$10.8M | ﹤0.01% | 2484 |
|
|
2023
Q3 | $10.8M | Sell |
397,846
-28,756
| -7% | -$780K | 0.01% | 807 |
|
|
2023
Q2 | $13.1M | Buy |
426,602
+96,782
| +29% | +$2.98M | 0.01% | 739 |
|
|
2023
Q1 | $11.9M | Sell |
329,820
-310,904
| -49% | -$11.2M | 0.01% | 828 |
|
|
2022
Q4 | $25.3M | Sell |
640,724
-41,062
| -6% | -$1.62M | 0.03% | 496 |
|
|
2022
Q3 | $27.4M | Buy |
681,786
+530,538
| +351% | +$21.3M | 0.03% | 439 |
|
|
2022
Q2 | $6.36M | Buy |
151,248
+69,947
| +86% | +$2.94M | 0.01% | 1327 |
|
|
2022
Q1 | $3.17M | Buy |
+81,301
| New | +$3.17M | ﹤0.01% | 2077 |
|
|
2021
Q3 | – | Sell |
-54,095
| Closed | -$2.22M | – | 3814 |
|
|
2021
Q2 | $2.22M | Buy |
+54,095
| New | +$2.22M | ﹤0.01% | 2012 |
|